StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.25−0.01 (-0.31%)

Close on Nov 18, 2026Market cap $23.95MP/E –Yield –

Immutep r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2026 it was A$76.66M, up 54.0% from the year before. Over ten years it grew 26.9% a year on average. The highest annual figure on record is A$76.66M in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$76.66M+54.0%
FY2025Jun 30, 2025A$49.78M+58.2%
FY2024Jun 30, 2024A$31.47M+9.3%
FY2023Jun 30, 2023A$28.79M+13.6%
FY2022Jun 30, 2022A$25.34M+110.8%
FY2021Jun 30, 2021A$12.02M-22.8%
FY2020Jun 30, 2020A$15.57M+13.1%
FY2019Jun 30, 2019A$13.77M+37.8%
FY2018Jun 30, 2018A$9.99M+32.7%
FY2017Jun 30, 2017A$7.53M+6.6%
FY2016Jun 30, 2016A$7.06M–

More Immutep figures

See a number that looks wrong?